Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial

INIS

• clinical trials 100%
• performance 100%
• doses 66%
• blood 66%
• concentration 66%
• alcohols 66%
• roads 66%
• women 33%
• risks 33%
• comparative evaluations 33%
• safety 33%
• size 33%
• netherlands 33%
• design 33%
• interventions 33%
• universities 33%
• psychology 33%
• vaporization 33%

Keyphrases

• Randomized Clinical Trial 100%
• Driving Performance 100%
• Cannabidiol 100%
• Δ9-tetrahydrocannabinol (Δ9-THC) 100%
• Cannabis 93%
• Placebo 60%
• Breath Alcohol Concentration (BrAC) 13%
• On-road Driving Test 13%
• Netherlands 6%
• Clinically Significant 6%
• No Significant Difference 6%
• Maastricht University 6%
• Drive Test 6%
• Standard Deviation of Lateral Position 6%
• Neuroscience 6%
• Driving Impairment 6%
• Cannabis Use 6%
• Crash Risk 6%
• Safety Concerns 6%
• Within-participants 6%
• Test Drive 6%
• Vaporized Cannabis 6%
• Occasional Users 6%
• Vaporization 6%
• Cannabis Consumption 6%
• Crossover Clinical Trial 6%

Medicine and Dentistry

• Cannabis 100%
• Tetrahydrocannabinol 100%
• Randomized Clinical Trial 100%
• Cannabidiol 100%
• Placebo 56%
• Nabiximols 31%
• Effect Size 6%
• Clinical Trial 6%
• Cannabis Use 6%
• Drive 6%